Status:
COMPLETED
Metabolism, Muscle Function and Psychological Factors in Fibromyalgia
Lead Sponsor:
Helsinki University Central Hospital
Collaborating Sponsors:
University of Helsinki
Conditions:
Fibromyalgia
Eligibility:
FEMALE
18-65 years
Phase:
NA
Brief Summary
Fibromyalgia (FM) is a world widely common syndrome, characterized by widespread pain, often accompanied by general fatigue, soreness, and abnormal sensations (like "pins and needles"). The reasons an...
Eligibility Criteria
Inclusion
- fibromyalgia diagnosed by the researchers RM or TZ, based on the ACR criteria from 1990
- Finnish as native language
Exclusion
- male sex
- muscular or neuromuscular diseases
- diabetes
- heart disease
- generalised atherosclerosis
- untreated hypertension
- neurological or other disease that systematically affects muscles
- a severe psychiatric disorder
- regular consumption of beta-blockers, bronchodilators, or statins
Key Trial Info
Start Date :
September 5 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 10 2019
Estimated Enrollment :
81 Patients enrolled
Trial Details
Trial ID
NCT03300635
Start Date
September 5 2015
End Date
April 10 2019
Last Update
December 13 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
HelsinkiUCH
Helsinki, Finland